News Events
December 6, 2007
Escape acquires key stem cell IP from Stanford.
Escape Therapeutics announces the acquisition of four stem cell related inventions from Stanford University, Stanford, CA. This intellectual property will form the foundation for Escape's proprietary universal stem cell platform technology.